US 12336980
Dosing regimen for a selective S1P1 receptor agonist
granted A61KA61K31/426A61K9/0053
Quick answer
US patent 12336980 (Dosing regimen for a selective S1P1 receptor agonist) held by VANDA PHARMACEUTICALS INC. expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/426, A61K9/0053, A61P, A61P1/00